Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA2
|
ENSG00000105996.5 | homeobox A2 |
HOXB1
|
ENSG00000120094.6 | homeobox B1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXA2 | hg19_v2_chr7_-_27142290_27142430 | 0.27 | 1.9e-01 | Click! |
HOXB1 | hg19_v2_chr17_-_46608272_46608385 | -0.04 | 8.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_12857015 | 3.70 |
ENST00000155926.4
|
TRIB2
|
tribbles pseudokinase 2 |
chr2_+_12857043 | 3.64 |
ENST00000381465.2
|
TRIB2
|
tribbles pseudokinase 2 |
chr4_-_90756769 | 2.53 |
ENST00000345009.4
ENST00000505199.1 ENST00000502987.1 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr4_-_90757364 | 2.53 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr4_-_102267953 | 2.52 |
ENST00000523694.2
ENST00000507176.1 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
chr1_-_92351769 | 1.84 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
chr16_-_49890016 | 1.71 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr17_+_7758374 | 1.61 |
ENST00000301599.6
ENST00000574668.1 |
TMEM88
|
transmembrane protein 88 |
chr20_+_42574317 | 1.29 |
ENST00000358131.5
|
TOX2
|
TOX high mobility group box family member 2 |
chr17_-_42277203 | 1.26 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr9_+_40028620 | 1.18 |
ENST00000426179.1
|
AL353791.1
|
AL353791.1 |
chr17_-_42276574 | 1.18 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr11_-_2162162 | 1.12 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr20_+_34802295 | 1.11 |
ENST00000432603.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chrX_-_10645773 | 1.03 |
ENST00000453318.2
|
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr13_-_110438914 | 0.96 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr12_-_15038779 | 0.95 |
ENST00000228938.5
ENST00000539261.1 |
MGP
|
matrix Gla protein |
chr7_+_79765071 | 0.95 |
ENST00000457358.2
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr7_-_86595190 | 0.94 |
ENST00000398276.2
ENST00000416314.1 ENST00000425689.1 |
KIAA1324L
|
KIAA1324-like |
chr7_-_120497178 | 0.91 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
chr18_-_53070913 | 0.90 |
ENST00000568186.1
ENST00000564228.1 |
TCF4
|
transcription factor 4 |
chr12_+_101988627 | 0.88 |
ENST00000547405.1
ENST00000452455.2 ENST00000441232.1 ENST00000360610.2 ENST00000392934.3 ENST00000547509.1 ENST00000361685.2 ENST00000549145.1 ENST00000553190.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr20_+_34742650 | 0.80 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr17_-_46623441 | 0.78 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
chr2_-_44588679 | 0.73 |
ENST00000409411.1
|
PREPL
|
prolyl endopeptidase-like |
chr2_-_44588694 | 0.72 |
ENST00000409957.1
|
PREPL
|
prolyl endopeptidase-like |
chr12_+_101988774 | 0.70 |
ENST00000545503.2
ENST00000536007.1 ENST00000541119.1 ENST00000361466.2 ENST00000551300.1 ENST00000550270.1 |
MYBPC1
|
myosin binding protein C, slow type |
chr18_+_56887381 | 0.69 |
ENST00000256857.2
ENST00000529320.2 ENST00000420468.2 |
GRP
|
gastrin-releasing peptide |
chr6_-_112575687 | 0.60 |
ENST00000521398.1
ENST00000424408.2 ENST00000243219.3 |
LAMA4
|
laminin, alpha 4 |
chr1_+_52082751 | 0.60 |
ENST00000447887.1
ENST00000435686.2 ENST00000428468.1 ENST00000453295.1 |
OSBPL9
|
oxysterol binding protein-like 9 |
chr15_-_74501310 | 0.59 |
ENST00000423167.2
ENST00000432245.2 |
STRA6
|
stimulated by retinoic acid 6 |
chr16_+_15596123 | 0.54 |
ENST00000452191.2
|
C16orf45
|
chromosome 16 open reading frame 45 |
chr6_+_151561085 | 0.53 |
ENST00000402676.2
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr15_-_93616892 | 0.51 |
ENST00000556658.1
ENST00000538818.1 ENST00000425933.2 |
RGMA
|
repulsive guidance molecule family member a |
chr6_-_112575838 | 0.50 |
ENST00000455073.1
|
LAMA4
|
laminin, alpha 4 |
chr10_-_65028938 | 0.50 |
ENST00000402544.1
|
JMJD1C
|
jumonji domain containing 1C |
chr2_-_242089677 | 0.47 |
ENST00000405260.1
|
PASK
|
PAS domain containing serine/threonine kinase |
chr12_+_57482877 | 0.46 |
ENST00000342556.6
ENST00000357680.4 |
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chrX_-_30993201 | 0.46 |
ENST00000288422.2
ENST00000378932.2 |
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr10_-_65028817 | 0.46 |
ENST00000542921.1
|
JMJD1C
|
jumonji domain containing 1C |
chr17_+_58755184 | 0.45 |
ENST00000589222.1
ENST00000407086.3 ENST00000390652.5 |
BCAS3
|
breast carcinoma amplified sequence 3 |
chr19_+_13051206 | 0.45 |
ENST00000586760.1
|
CALR
|
calreticulin |
chr14_+_22985251 | 0.44 |
ENST00000390510.1
|
TRAJ27
|
T cell receptor alpha joining 27 |
chr3_-_51813009 | 0.42 |
ENST00000398780.3
|
IQCF6
|
IQ motif containing F6 |
chr10_+_89264625 | 0.40 |
ENST00000371996.4
ENST00000371994.4 |
MINPP1
|
multiple inositol-polyphosphate phosphatase 1 |
chr6_-_112575912 | 0.39 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr6_-_112575758 | 0.39 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr13_+_97928395 | 0.38 |
ENST00000445661.2
|
MBNL2
|
muscleblind-like splicing regulator 2 |
chr15_-_74501360 | 0.38 |
ENST00000323940.5
|
STRA6
|
stimulated by retinoic acid 6 |
chr5_-_125930929 | 0.38 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
chr13_+_36050881 | 0.35 |
ENST00000537702.1
|
NBEA
|
neurobeachin |
chr14_+_68189190 | 0.35 |
ENST00000539142.1
|
RDH12
|
retinol dehydrogenase 12 (all-trans/9-cis/11-cis) |
chr17_+_36584662 | 0.34 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr19_+_47421933 | 0.34 |
ENST00000404338.3
|
ARHGAP35
|
Rho GTPase activating protein 35 |
chr15_+_48009541 | 0.32 |
ENST00000536845.2
ENST00000558816.1 |
SEMA6D
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
chr2_+_242089833 | 0.30 |
ENST00000404405.3
ENST00000439916.1 ENST00000406106.3 ENST00000401987.1 |
PPP1R7
|
protein phosphatase 1, regulatory subunit 7 |
chr6_+_32006042 | 0.27 |
ENST00000418967.2
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr17_-_57229155 | 0.24 |
ENST00000584089.1
|
SKA2
|
spindle and kinetochore associated complex subunit 2 |
chr16_+_85645007 | 0.23 |
ENST00000405402.2
|
GSE1
|
Gse1 coiled-coil protein |
chr2_+_135011731 | 0.23 |
ENST00000281923.2
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
chr4_+_129732467 | 0.23 |
ENST00000413543.2
|
PHF17
|
jade family PHD finger 1 |
chr10_+_124320156 | 0.21 |
ENST00000338354.3
ENST00000344338.3 ENST00000330163.4 ENST00000368909.3 ENST00000368955.3 ENST00000368956.2 |
DMBT1
|
deleted in malignant brain tumors 1 |
chr10_+_124320195 | 0.19 |
ENST00000359586.6
|
DMBT1
|
deleted in malignant brain tumors 1 |
chr17_+_37824700 | 0.19 |
ENST00000581428.1
|
PNMT
|
phenylethanolamine N-methyltransferase |
chr17_+_39975544 | 0.18 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr17_+_39975455 | 0.18 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr6_+_32006159 | 0.18 |
ENST00000478281.1
ENST00000471671.1 ENST00000435122.2 |
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr1_+_243419306 | 0.17 |
ENST00000355875.4
ENST00000391846.1 ENST00000366541.3 ENST00000343783.6 |
SDCCAG8
|
serologically defined colon cancer antigen 8 |
chr15_-_93616340 | 0.17 |
ENST00000557420.1
ENST00000542321.2 |
RGMA
|
repulsive guidance molecule family member a |
chr13_+_52586517 | 0.16 |
ENST00000523764.1
ENST00000521508.1 |
ALG11
|
ALG11, alpha-1,2-mannosyltransferase |
chr11_+_57365150 | 0.16 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr3_+_189507460 | 0.15 |
ENST00000434928.1
|
TP63
|
tumor protein p63 |
chr5_+_133861790 | 0.15 |
ENST00000395003.1
|
PHF15
|
jade family PHD finger 2 |
chr15_+_75335604 | 0.14 |
ENST00000563393.1
|
PPCDC
|
phosphopantothenoylcysteine decarboxylase |
chr12_+_7282795 | 0.14 |
ENST00000266546.6
|
CLSTN3
|
calsyntenin 3 |
chr6_+_151561506 | 0.14 |
ENST00000253332.1
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr2_-_200322723 | 0.13 |
ENST00000417098.1
|
SATB2
|
SATB homeobox 2 |
chr5_+_147582348 | 0.12 |
ENST00000514389.1
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6 |
chr7_-_100881041 | 0.12 |
ENST00000412417.1
ENST00000414035.1 |
CLDN15
|
claudin 15 |
chr12_-_28124903 | 0.12 |
ENST00000395872.1
ENST00000354417.3 ENST00000201015.4 |
PTHLH
|
parathyroid hormone-like hormone |
chr2_-_200323414 | 0.11 |
ENST00000443023.1
|
SATB2
|
SATB homeobox 2 |
chr1_-_182641367 | 0.11 |
ENST00000508450.1
|
RGS8
|
regulator of G-protein signaling 8 |
chr7_+_26591441 | 0.11 |
ENST00000420912.1
ENST00000457000.1 ENST00000430426.1 |
AC004947.2
|
AC004947.2 |
chr1_-_182642017 | 0.11 |
ENST00000367557.4
ENST00000258302.4 |
RGS8
|
regulator of G-protein signaling 8 |
chrY_+_26997726 | 0.11 |
ENST00000382296.2
|
DAZ4
|
deleted in azoospermia 4 |
chr7_-_144107320 | 0.11 |
ENST00000483238.1
ENST00000467773.1 |
NOBOX
|
NOBOX oogenesis homeobox |
chr17_+_21729593 | 0.11 |
ENST00000581769.1
ENST00000584755.1 |
UBBP4
|
ubiquitin B pseudogene 4 |
chr9_-_101471479 | 0.11 |
ENST00000259455.2
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr17_-_27418537 | 0.11 |
ENST00000408971.2
|
TIAF1
|
TGFB1-induced anti-apoptotic factor 1 |
chr17_+_79495397 | 0.09 |
ENST00000417245.2
ENST00000334850.7 |
FSCN2
|
fascin homolog 2, actin-bundling protein, retinal (Strongylocentrotus purpuratus) |
chr17_+_43239231 | 0.09 |
ENST00000591576.1
ENST00000591070.1 ENST00000592695.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
chr3_+_191046810 | 0.09 |
ENST00000392455.3
ENST00000392456.3 |
CCDC50
|
coiled-coil domain containing 50 |
chr3_-_156877997 | 0.08 |
ENST00000295926.3
|
CCNL1
|
cyclin L1 |
chrX_+_99899180 | 0.08 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
chr7_-_14029283 | 0.08 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chr10_+_102505468 | 0.07 |
ENST00000361791.3
ENST00000355243.3 ENST00000428433.1 ENST00000370296.2 |
PAX2
|
paired box 2 |
chr4_+_77356248 | 0.07 |
ENST00000296043.6
|
SHROOM3
|
shroom family member 3 |
chr1_-_109584768 | 0.07 |
ENST00000357672.3
|
WDR47
|
WD repeat domain 47 |
chr1_+_12524965 | 0.07 |
ENST00000471923.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
chr3_+_148545586 | 0.06 |
ENST00000282957.4
ENST00000468341.1 |
CPB1
|
carboxypeptidase B1 (tissue) |
chr1_-_109584716 | 0.06 |
ENST00000531337.1
ENST00000529074.1 ENST00000369965.4 |
WDR47
|
WD repeat domain 47 |
chr1_-_108507631 | 0.05 |
ENST00000527011.1
ENST00000370056.4 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr7_-_14029515 | 0.05 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
chr14_-_21516590 | 0.05 |
ENST00000555026.1
|
NDRG2
|
NDRG family member 2 |
chr1_+_178062855 | 0.05 |
ENST00000448150.3
|
RASAL2
|
RAS protein activator like 2 |
chr5_+_167181917 | 0.05 |
ENST00000519204.1
|
TENM2
|
teneurin transmembrane protein 2 |
chr9_+_132099158 | 0.05 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr1_-_109584608 | 0.05 |
ENST00000400794.3
ENST00000528747.1 ENST00000369962.3 ENST00000361054.3 |
WDR47
|
WD repeat domain 47 |
chr7_-_100881109 | 0.03 |
ENST00000308344.5
|
CLDN15
|
claudin 15 |
chr6_+_29426230 | 0.03 |
ENST00000442615.1
|
OR2H1
|
olfactory receptor, family 2, subfamily H, member 1 |
chr21_-_43430440 | 0.02 |
ENST00000398505.3
ENST00000310826.5 ENST00000449949.1 ENST00000398499.1 ENST00000398497.2 ENST00000398511.3 |
ZBTB21
|
zinc finger and BTB domain containing 21 |
chrX_+_125953746 | 0.02 |
ENST00000371125.3
|
CXorf64
|
chromosome X open reading frame 64 |
chr7_+_20370746 | 0.02 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
chr10_+_95848824 | 0.02 |
ENST00000371385.3
ENST00000371375.1 |
PLCE1
|
phospholipase C, epsilon 1 |
chr13_-_36050819 | 0.02 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr1_-_43833628 | 0.02 |
ENST00000413844.2
ENST00000372458.3 |
ELOVL1
|
ELOVL fatty acid elongase 1 |
chr3_+_189507523 | 0.01 |
ENST00000437221.1
ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63
|
tumor protein p63 |
chr10_-_46342921 | 0.01 |
ENST00000448048.2
|
AGAP4
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 |
chr1_-_67390474 | 0.01 |
ENST00000371023.3
ENST00000371022.3 ENST00000371026.3 ENST00000431318.1 |
WDR78
|
WD repeat domain 78 |
chr8_+_143530791 | 0.01 |
ENST00000517894.1
|
BAI1
|
brain-specific angiogenesis inhibitor 1 |
chr2_+_26624775 | 0.01 |
ENST00000288710.2
|
DRC1
|
dynein regulatory complex subunit 1 homolog (Chlamydomonas) |
chr11_-_122930121 | 0.01 |
ENST00000524552.1
|
HSPA8
|
heat shock 70kDa protein 8 |
chr20_+_21283941 | 0.01 |
ENST00000377191.3
ENST00000430571.2 |
XRN2
|
5'-3' exoribonuclease 2 |
chr8_-_38008783 | 0.01 |
ENST00000276449.4
|
STAR
|
steroidogenic acute regulatory protein |
chr20_+_21284416 | 0.01 |
ENST00000539513.1
|
XRN2
|
5'-3' exoribonuclease 2 |
chr17_-_1588101 | 0.00 |
ENST00000577001.1
ENST00000572621.1 ENST00000304992.6 |
PRPF8
|
pre-mRNA processing factor 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 7.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.0 | 5.1 | GO:0051945 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.8 | 2.5 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.5 | 1.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 1.0 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.2 | 1.0 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.1 | 0.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.1 | 1.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 2.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 0.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 1.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.0 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 1.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 1.0 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.0 | 1.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 1.7 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.3 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.1 | GO:0072179 | vestibulocochlear nerve formation(GO:0021650) pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) kidney field specification(GO:0072004) nephric duct formation(GO:0072179) positive regulation of metanephric glomerulus development(GO:0072300) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.3 | 2.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 2.4 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 5.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.6 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.0 | 1.9 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.0 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 5.1 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.4 | 7.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 2.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.4 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.1 | 0.9 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 1.6 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 1.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.0 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 2.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 2.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 1.0 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 1.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 1.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.4 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 2.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 1.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 2.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |